Phase IIIThyroid Analog
Compound 61982
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061982
Risk Class
HIGH
Last Audit
Nov 7, 2108
Research Abstract
Thyroid Analog candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 61982 is a thyroid analog asset inside thyroid analog innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in phase iii with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-061982 with updates logged 2108-11-07.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-61982Thyroid Analog Program 61982
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061982
- [2] Operations Pulse • Thyroid Analog innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-61982